Why the study?
A presystolic wave on LVOT Doppler is thought to reflect LV stiffness and impaired compliance, but its relationship with dipper versus nondipper hypertension remained to be evaluated.
Is the presence of a presystolic wave on echocardiography associated with nondipper hypertension?
Is the presence of a presystolic wave on echocardiography associated with nondipper hypertension?
Answers are grounded in this paper and cite their sources.
Presystolic wave on echocardiography was associated with nondipper hypertension; hypothesis-generating and should not yet change practice.
BACKGROUND: A presystolic wave (PSW) is commonly seen on Doppler examination of the left ventricular outflow tract (LVOT), and the possible mechanism for PSW is considered to be left ventricular stiffness and impaired LV compliance. We aimed to compare the relationship between PSW and dipper, nondipper hypertension. PATIENTS AND METHODS: A total of 83 patients were included in the study. The participating patients were divided into two groups as 42 patients with dipper hypertension and 41 patients with nondipper hypertension based on the results of ambulatory blood pressure monitoring. RESULTS: Left ventricular mass index (91.6 ± 12.9 vs. 106.1 ± 7.9, P < 0.001) and E/Em (7.4 [6.6-8.3] vs. 10 [8-12], P < 0.001) were significantly higher, and Em (9.9 ± 2.7 vs. 7.9 ± 3.4, P = 0.004) was significantly lower in the nondipper group compared with dipper group. And also, the PSW was found to be higher in the nondipper group. The nondipper group had markedly increased frequencies of PSW compared with the dipper group (68 vs. 38%, respectively, P = 0.008). In the multivariate logistic regression test, E/Em [odds ratio (OR) 1.464, 95% confidence interval (CI): 1.113-1.926, P = 0.006] and the presence of PSW (OR 3.115, 95% CI: 1.061-9.143, P = 0.039) were determined as independent predictive parameters for nondipper hypertension. CONCLUSION: The presence of PSW on transthoracic echocardiography suggests that we may come across nondipper hypertension and a high risk of end-organ damage. PSW may be used as a useful parameter in risk stratification in hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Kahyaoğlu et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: